Adial Pharmaceuticals Inc (ADIL) Stock: What Does the Chart Say Friday?

Adial Pharmaceuticals Inc (ADIL) stock has gained 1.61% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Adial Pharmaceuticals Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on ADIL!

See Full ADIL Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With ADIL Stock Today?

Adial Pharmaceuticals Inc (ADIL) stock is up 6.78% while the S&P 500 is lower by -0.3% as of 3:26 PM on Friday, Dec 29. ADIL has gained $0.12 from the previous closing price of $1.77 on volume of 1,140,895 shares. Over the past year the S&P 500 has gained 26.06% while ADIL is lower by -65.64%. ADIL lost -$5.61 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Adial Pharmaceuticals Inc click here.

More About Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. Click Here to get the full Stock Report for Adial Pharmaceuticals Inc stock.